Preprint · OA
via OpenAlex
The gut microbiota metabolite Urolithin A mitigates JAK signaling to suppress cytokine–mediated autoimmune diseases
Shijin Geng, Rong-Chun Tang, Hengxiang Yu, A R Zhang, Shuang‐Shuang Yu, Yunxuan Zhou, Lan Zhang, Jun Zhang
bioRxiv (Cold Spring Harbor Laboratory) · 2026
Abstract
Abstract Aberrant activation of type I interferon (IFN-I) is closely related to the development of autoimmune diseases. The metabolic regulation of cytokine signaling is essential for immune homeostasis. In this study, we characterized Urolithin A(UA), a natural gut-derived metabolite, as an inhibitor of Janus kinase (JAK) signaling. UA was found to broadly dampen JAK phosphorylation and the downstream signaling induced by cytokines such as type I interferons (IFN-I), type II interferons (IFN-II), and interleukin-6 (IL-6). UA can directly bind to JAK1 JH1 domain and treatment with UA attenuated autoimmune pathogenesis in Trex1 -KO mice, IMQ-induced SLE and psoriasis models. Our findings unveil that UA is an anti-inflammatory metabolite that promotes immune homeostasis and could be used to treat inflammatory and autoimmune diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.64898/2026.05.08.723914
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Geng, S., Tang, R., Yu, H., Zhang, A.R., Yu, S., Zhou, Y., Zhang, L., & Zhang, J. (2026). The gut microbiota metabolite Urolithin A mitigates JAK signaling to suppress cytokine–mediated autoimmune diseases. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.64898/2026.05.08.723914
Vancouver
Geng S, Tang R, Yu H, Zhang AR, Yu S, Zhou Y, et al. The gut microbiota metabolite Urolithin A mitigates JAK signaling to suppress cytokine–mediated autoimmune diseases. bioRxiv (Cold Spring Harbor Laboratory). 2026. doi:10.64898/2026.05.08.723914.
BibTeX
@unpublished{shijin2026Thegut,
title = {The gut microbiota metabolite Urolithin A mitigates JAK signaling to suppress cytokine–mediated autoimmune diseases},
author = {Shijin Geng and Rong-Chun Tang and Hengxiang Yu and A R Zhang and Shuang‐Shuang Yu and Yunxuan Zhou and Lan Zhang and Jun Zhang},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2026},
doi = {10.64898/2026.05.08.723914},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Proceedings of the National Academy of Sciences 2011
Open access · OA
Lethal mitochondrial cardiomyopathy in a hypomorphic <i>Med30</i> mouse mutant is ameliorated by ketogenic diet
Annual Review of Medicine 2017
Open access · OA
Innate Immunity and Neurodegeneration
Microorganisms 2020
Open access · CC-BY
Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases
Nippon Eiyo Shokuryo Gakkaishi 2023
Open access · OA
Development of the Functional Intestinal Metabolite Urolithin A
FEMS Microbiology Ecology 2024
Open access · CC-BY
Can longer lifespan be associated with gut microbiota involvement in lipid metabolism?
Genes & Development 2009
Preprint · OA